Biocartis announced the launch of its real-time quantitative polymerase chain reaction assay to detect POLE and POLD1 ...

AliveDx has submitted a 510(k) premarket notification seeking approval from the FDA for its MosaiQ AiPlex CTDplus microarray.

SkylineDx, an innovative diagnostics company specializing in molecular diagnostics for oncology, inflammatory, and infectious diseases, ...

The following is a summary of “Impaired LTB4-induced neutrophil chemotactic directionality in myelodysplastic neoplasms ...

The Switzerland-based firm's MosaiQ AiPlex Connective Tissue Diseases (CTDplus) assay is used to aid the diagnosis of autoimmune diseases.

The firm's next-generation sequencing-based test detects single nucleotide variants, insertions, and deletions in 22 genes.

Western Tethyan Resources, which is 76%-owned by Ariana, met its phase one earn-in requirements after completing a EUR800,000 exploration spend. The milestone triggers WTR's official ownership of 51% ...

Vanzwa, H.M., Manzemu, D.G., Kampunzu, V.M., Sadiki, D.F., Kasaï, E.T. and Opara, J.P.A. (2025) Interest of Serum Procalcitonin in the Diagnosis of Early Neonatal Bacterial Infections in Kisangani.

Blackstone Minerals (ASX: BSX) has received promising historical assay results from the deepest hole drilled at its new ...

SEKISUI Diagnostics is a well-known provider of many rapid diagnostic solutions to the professional and home testing markets ...

Pharmaceuticals presented extended results from its validated research-use plasma pTau217 assay to screen potential participants ...